- Volume 15 Issue 12
DOI QR Code
Cervical Cancer Gene Therapy by Gene Loaded PEG-PLA Nanomedicine
- Liu, Bo (Department of Internal Medicine Oncology, Shandong Tumor Hospital and Institute) ;
- Han, Shu-Mei (Department of Internal Medicine Oncology, Shandong Tumor Hospital and Institute) ;
- Tang, Xiao-Yong (Department of Internal Medicine Oncology, Shandong Tumor Hospital and Institute) ;
- Han, Li (Department of Internal Medicine Oncology, Shandong Tumor Hospital and Institute) ;
- Li, Chang-Zhong (Department of Gynecology, Shandong Provincial Hospital Affiliated to Shandong University)
- Published : 2014.06.30
Background and Aims: Advances in the treatment of cervical cancer over the last decade have predominantly involved the development of genes directed at molecular targets. Gene therapy is recognized to be a novel method for the treatment of cervical cancer. Genes can be administered into target cells via nanocarriers. This study aimed to develop systemically administrable nano-vectors. Floate (Fa) containing gene loaded nanoparticles (NPs) could target HeLa human cervical cancer cells through combination with receptors on the cells to increase the nuclear uptake of genetic materials. Methods: Fa was linked onto Poly (ethylene glycol)-b-poly (D, L-lactide) (PEG-PLA) to form Fa-PEG-PLA, and the resulting material was used to load plasmids of enhanced green fluorescence protein (pEGFP) to obtain gene loaded nanoparticles (Fa-NPs/DNA). Physical-chemical characteristics, in vitro release and cytotoxicity of Fa-NPs/DNA were evaluated. The in vitro transfection efficiency of Fa-NPs/DNA was evaluated in HeLa cells and human umbilical vein endothelial cells (HUVEC). PEG-PLA without Fa was used to load pEGFP from NPs/DNA as a control. Results: Fa-NPs/DNA has a particle size of 183 nm and a gene loading quantity of 92%. After 72h of transfection, Fa-NPs/DNA displayed over 20% higher transfection efficiency than NPs/DNA and 40% higher than naked DNA in HeLa cells. However, in HUVECs, no significant difference appeared between Fa-NPs/DNA and NPs/DNA. Conclusions: Fa-PEG-PLA NPs could function as excellent materials for gene loading. This nano-approach could be used as tumor cell targeted medicine for the treatment of cervical cancer.
- Vachani A, Moon E, Wakeam E, et al (2011). Gene therapy for lung neoplasms. Clin Chest Med, 32, 865-85. https://doi.org/10.1016/j.ccm.2011.08.006
- Zhao LW, Zhong XH, Yang SY et al (2014). Inotodiol inhabits proliferation and induces apoptosis through modulating expression of cycline, p27, bcl-2, and bax in human cervical cancer Hela cells. Asian Pac J Cancer Prev, 15, 3195-9. https://doi.org/10.7314/APJCP.2014.15.7.3195
- Zhang L, Hu CH, Cheng SX, Zhuo RX (2010). Hyperbranched amphiphilic polymer with folate mediated targeting property. Colloids Surf B Biointerfaces, 79, 427-33. https://doi.org/10.1016/j.colsurfb.2010.05.014
- Zhou X, Gu Y, Zhang SL (2012). Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis. Asian Pac J Cancer Prev, 13, 4909-14. https://doi.org/10.7314/APJCP.2012.13.10.4909
- Tsai HC, Chang WH, Lo CL, et al (2010). Graft and diblock copolymer multifunctional micelles for cancer chemotherapy and imaging. Biomaterials, 31, 2293-301. https://doi.org/10.1016/j.biomaterials.2009.11.059
- Tungsrithong N, Kasinpila C, Maneenin C, et al (2014). Lack of significant effects of Chlamydia trachomatis infection on cervical cancer risk in a nested case-control study in North-East Thailand. Asian Pac J Cancer Prev, 15, 1497-500. https://doi.org/10.7314/APJCP.2014.15.3.1497
- Wang S, Luo Y, Zeng S, et al (2013). Dodecanol-poly (D, L-lactic acid)-b-poly (ethylene glycol)-folate (Dol-PLA-PEG-FA) nanoparticles: evaluation of cell cytotoxicity and selecting capability in vitro. Colloids Surf B Biointerfaces, 102, 130-5. https://doi.org/10.1016/j.colsurfb.2012.07.030
- Wang YQ, Su J, Wu F, et al (2012). Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, low cytotoxicity, and high efficiency for gene delivery. Int J Nanomedicine, 7, 693-704.
- Xia H, Gao X, Gu G, et al (2012). Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery. Int J Pharm, 436, 840-50. https://doi.org/10.1016/j.ijpharm.2012.07.029
- Xiao RZ, Zeng ZW, Zhou GL, et al (2010). Recent advances in PEG-PLA block copolymer nanoparticles. Int J Nanomedicine, 5, 1057-65.
- Yang S, Chen Y, Gu K, et al (2013). Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells. Int J Nanomedicine, 8, 2847-58.
- Yu DH, Lu Q, Xie J, et al (2010). Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Biomaterials, 31, 2278-92. https://doi.org/10.1016/j.biomaterials.2009.11.047
- Yu W, Liu C, Liu Y, et al (2010). Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res, 27, 1584-96. https://doi.org/10.1007/s11095-010-0149-z
- Narayan G, Murty VV (2010). Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis. Future Oncol, 6, 1643-52. https://doi.org/10.2217/fon.10.114
- Luu HN, Dahlstrom KR, Mullen PD, et al (2013). Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis. Cancer Med, 2, 367-90. https://doi.org/10.1002/cam4.83
- Ma JQ, Kurban S, Zhao JD, et al (2014). Epigenetic regulation of human riboflavin transporter 2 (hRFT2) in cervical cancers from Uighur women. Asian Pac J Cancer Prev, 15, 2485-9. https://doi.org/10.7314/APJCP.2014.15.6.2485
- Meads C, Auguste P, Davenport C, et al (2013). Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling. Health Technol Assess, 17, 1-323.
- Parveen S, Misra R, Sahoo SK (2012). Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine, 8, 147-66. https://doi.org/10.1016/j.nano.2011.05.016
- Podolska K, Stachurska A, Hajdukiewicz K, Malecki M (2012). Gene therapy prospects--intranasal delivery of therapeutic genes. Adv Clin Exp Med, 21, 525-34.
- Schadlich A, Caysa H, Mueller T, et al (2011). Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model. ACS Nano, 5, 8710-20. https://doi.org/10.1021/nn2026353
- Shi Y, Huang W, Liang R, et al (2013). Improvement of in vivo efficacy of recombinant human erythropoietin by encapsulation in PEG-PLA micelle. Int J Nanomedicine, 8, 1-11. https://doi.org/10.2217/nnm.12.179
- Takai N, Kira N, Ishii T, et al (2011). Novel chemotherapy using histone deacetylase inhibitors in cervical cancer. Asian Pac J Cancer Prev, 12, 575-80.
- Gao X, Tao W, Lu W, et al (2006). Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. Biomaterials, 27, 3482-90. https://doi.org/10.1016/j.biomaterials.2006.01.038
- Elfinger M, Maucksch C, Rudolph C. (2007). Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells. Biomaterials, 28, 3448-55. https://doi.org/10.1016/j.biomaterials.2007.04.011
- Elzoghby AO (2013). Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research. J Control Release, 172, 1075-91. https://doi.org/10.1016/j.jconrel.2013.09.019
- Filipi K, Xhani A (2014). Assessment of cervical cytological data in Albanian females. Asian Pac J Cancer Prev, 15, 2129-32. https://doi.org/10.7314/APJCP.2014.15.5.2129
- Geiger J, Aneja MK, Hasenpusch G, et al (2010). Targeting of the prostacyclin specific IP1 receptor in lungs with molecular conjugates comprising prostaglandin I2 analogues. Biomaterials, 31, 2903-11. https://doi.org/10.1016/j.biomaterials.2009.12.035
- Gersch ED, Gissmann L, Garcea RL (2012). New approaches to prophylactic human papillomavirus vaccines for cervical cancer prevention. Antivir Ther, 17, 425-34.
- Kahla S, Kochbati L, Maalej M, et al (2014). Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma. Asian Pac J Cancer Prev, 15, 2869-73. https://doi.org/10.7314/APJCP.2014.15.6.2869
- Karadag G, Gungormus Z, Surucu R, et al (2014). Awareness and practices regarding breast and cervical cancer among Turkish women in Gazientep. Asian Pac J Cancer Prev, 15, 1093-8. https://doi.org/10.7314/APJCP.2014.15.3.1093
- Lee H, Kim Y, Schweickert PG, et al (2014). A photodegradable gene delivery system for enhanced nuclear gene transcription. Biomaterials, 35, 1040-9. https://doi.org/10.1016/j.biomaterials.2013.10.030
- Lin C, Huang F, Zhang YJ, et al (2014). Roles of MiR-101 and its target gene Cox-2 in early diagnosis of cervical cancer in Uygur women. Asian Pac J Cancer Prev, 15, 45-8. https://doi.org/10.7314/APJCP.2014.15.1.45
- AAntic LG, Djikanovic BS, Antic DZ, et al (2014). Differencies in the level of knowledge on cervical cancer among health care students, midwives and patients in Serbia. Asian Pac J Cancer Prev, 15, 3011-5. https://doi.org/10.7314/APJCP.2014.15.7.3011
- Buyens K, De Smedt SC, Braeckmans K, et al (2012). Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design. J Control Release, 158, 362-70. https://doi.org/10.1016/j.jconrel.2011.10.009
- Chen Y, Zhu X, Zhang X, et al (2010). Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Ther, 18, 1650-6. https://doi.org/10.1038/mt.2010.136
- Isomeric Folate-Conjugated Polymeric Micelles Bind to Folate Receptors and Display Anticancer Effects vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7363
- Nanotechnology in the management of cervical cancer vol.25, pp.10529276, 2015, https://doi.org/10.1002/rmv.1825
- Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood vol.44, pp.22, 2015, https://doi.org/10.1039/C5CS00499C
- Recent advances on biocompatible and biodegradable nanoparticles as gene carriers vol.16, pp.6, 2016, https://doi.org/10.1517/14712598.2016.1169269
- Molecular Communication and Nanonetwork for Targeted Drug Delivery: A Survey vol.19, pp.4, 2017, https://doi.org/10.1109/COMST.2017.2705740